A&G Pharmaceutical, Inc. Product Pipeline Analysis

SUMMARY

A&G Pharmaceutical, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a A&G Pharmaceutical, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List Of Tables 5
1.2 List of Figures 6
2 Company Overview 7
2.1 Key Information 7
2.2 Industry Outlook -- In Vitro Diagnostics 7
3 Major Products and Services 8
3.1 Overview 8
4 Competitors 9
5 Key Employees 10
6 Locations And Subsidiaries 11
6.1 Head Office 11
7 Recent Developments 12
7.1 Product News 12
7.1.1 Dec 14, 2007: A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer 12
7.1.2 Feb 17, 2006: Maryland Company Developing New Breast Cancer Test Kit 12
7.1.3 Sep 08, 2005: A&G Pharmaceutical Completes Series A Financing 12
8 A&G Pharmaceutical, Inc. Pipeline Products 13
8.1 A&G Pharmaceutical, Inc. Product Pipeline Analysis 13
8.1.1 A&G Pharmaceutical, Inc. Pipeline Products By Equipment Type 13
8.1.2 A&G Pharmaceutical, Inc. Pipeline Products By Development Stage 14
8.1.3 A&G Pharmaceutical, Inc. Pipeline Products By Therapy Area 14
8.1.4 A&G Pharmaceutical, Inc. Pipeline Products By News Summary 15
8.2 Oncostain GP88 blood diagnostic test 15
8.2.1 Product Description 15
8.2.2 Product Status 15
8.2.3 Product Milestone 16
8.2.4 Product Patent Details 16
8.3 GP88 First Screen 17
8.3.1 Product Description 17
8.3.2 Product Status 17
8.4 GP88 Biopsy Staining Kit 18
8.4.1 Product Description 18
8.4.2 Product Status 18
8.5 GP88 Serum Monitoring Kit 18
8.5.1 Product Description 19
8.5.2 Product Status 19
9 Appendix 20
9.1 Methodology 20
9.1.1 Coverage 20
9.1.2 Secondary Research 21
9.1.3 Primary Research 21
9.1.4 Expert Panel Validation 22
9.2 Contact Us 22
9.3 About Global Markets Direct 22
9.4 Disclaimer 22

1.1 List of Tables
Table 1: A&G Pharmaceutical, Inc.,Key Facts 7
Table 2: A&G Pharmaceutical, Inc., Key Employees, 10
Table 3: A&G Pharmaceutical, Inc. Pipeline Products by Equipment Type 13
Table 4: A&G Pharmaceutical, Inc. Pipeline Products By Development Stage 14
Table 5: A&G Pharmaceutical, Inc. Pipeline Products By Therapy Area 14
Table 6: A&G Pharmaceutical, Inc. Pipeline Products By News Summaries 15

1.2 List of Figures
Figure 1: A&G Pharmaceutical, Inc. Pipeline Products By Development Stage 14
Figure 2: Global Markets Direct Methodology 20